Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer?
Author:
Publisher
Elsevier BV
Subject
Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery
Reference33 articles.
1. Perioperative therapy for muscle invasive bladder cancer;Leow;Hematol Oncol Clin North Am,2015
2. Trends in the use of perioperative chemotherapy for localized and locally advanced muscle-invasive bladder cancer: a sign of changing tides;Reardon;Eur Urol,2015
3. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer;Grossman;N Engl J Med,2003
4. Refining patient selection for neoadjuvant chemotherapy before radical cystectomy;Culp;J Urol,2014
5. Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy;Canter;BJU Int,2011
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of a New Cystoscopic Cryocatheter and Method for the In Situ Destruction of Bladder Cancer: Preliminary In vivo Study;Journal of Endourology;2024-01-27
2. Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the Literature;PharmacoEconomics;2023-04-23
3. Complete transurethral resection of bladder tumor before radical cystectomy is not a risk factor for organ-confined bladder cancer: A case-control study;Current Urology;2022-08-27
4. Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer;Journal of Cancer Research and Clinical Oncology;2022-01-08
5. Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?;European Urology Oncology;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3